Navigation Links
Cell Therapeutics Files Appeal on FDA Decision on New Drug Application (NDA) for Pixantrone to Treat Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma
Date:12/3/2010

SEATTLE, Dec. 3, 2010 /PRNewswire/ -- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) today announced that it has submitted a formal appeal to the Office of New Drugs in the U.S. Food and Drug Administration's Center for Drug Evaluation and Research regarding the agency's decision from earlier this year on the pixantrone New Drug Application ("NDA") to treat relapsed/refractory aggressive non-Hodgkin's lymphoma ("NHL"). CTI had requested accelerated approval of its pixantrone NDA for a patient group for which there are no drugs currently approved in this clinical setting. The Office of Oncology Drug Products issued a Complete Response Letter to CTI related to this NDA stating, in part, that CTI's prior clinical trial, PIX301, did not demonstrate efficacy, and that CTI should conduct an additional clinical trial prior to approval. Although CTI is preparing to initiate its PIX306 trial, which would serve as either a post-approval confirmatory trial or a second registration trial for approval, CTI has filed an appeal under the FDA's formal dispute resolution process asking the Office of New Drugs to conclude that PIX301 demonstrated efficacy.

"We believe the FDA diverged from accepted statistical principles and practices when the FDA applied a more stringent statistical significance level in concluding that the PIX301 primary analysis required an adjustment for type 1 error as if an interim analysis had been conducted. This was not the case in the PIX301 trial where only a single final analysis was undertaken," said Richard Kay, PhD, Statistical Consultant, RK Statistics Ltd., Honorary Visiting Professor, School of Pharmacy, Cardiff University. "We believe the results of the PIX301 clinical trial should be analyzed with the appropriate threshold that is standard for trials of this type in which only one efficacy analysis was conducted."

FDA regulations provide a formal dispute resolution process to obtain review of any FDA decision, including a
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)...  Volcano Corporation (Nasdaq: VOLC ), ... economic outcomes on a global basis by developing ... visualization, physiology diagnostics and therapies, today confirmed receipt ... from Engaged Capital, LLC.  The Company issued the ... welcomes the perspectives of its shareholders, and has ...
(Date:9/29/2014)... YORK , Sept. 29, 2014 ... Summary GlobalData,s new report, "EU5 Esophagoscopes ... market data on the EU5 Esophagoscopes & Gastroscopes ... US dollars, volume (in units) and average prices ... Video Esophagoscopes, Flexible Non-Video (Fibre) Gastroscopes and Flexible ...
(Date:9/29/2014)... Colombia , Sept. 29, 2014  Cancer ... has announced a promising new drug treatment: a ... (3-BrPA) that has already proven successful at treating ... researchers behind this novel treatment are optimistic that ... who have exhausted current therapeutic avenues. ...
Breaking Medicine Technology:Volcano Issues Statement Regarding Letter From Engaged Capital 2Volcano Issues Statement Regarding Letter From Engaged Capital 3EU5 Esophagoscopes & Gastroscopes Market Outlook to 2020 2EU5 Esophagoscopes & Gastroscopes Market Outlook to 2020 3Cancer Treatment Institute of Colombia Demonstrates Unprecedented Results Using Unique Cancer Drug Combination of 3-Bromopyruvate and Salinomycin for Treatment of Multiple Types of Cancer 2Cancer Treatment Institute of Colombia Demonstrates Unprecedented Results Using Unique Cancer Drug Combination of 3-Bromopyruvate and Salinomycin for Treatment of Multiple Types of Cancer 3
... SAN DIEGO , July 29 Orexigen® Therapeutics, Inc. (Nasdaq: ... its second quarter ended June 30, 2010 financial results on ... followed by a live webcast and conference call at 5:00 p.m. Eastern ... Orexigen management will ...
... , EMERYVILLE, Calif. , July 29 Bionovo, Inc. ... from the European Medicines Agency (EMA) in order to advance Menerba, the ... in Europe . The guidance defines the clinical and regulatory pathway ... , , ...
Cached Medicine Technology:Orexigen® Therapeutics Schedules August 5, 2010 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2010 2Bionovo to Advance Menerba to Phase 3 Clinical Testing in Europe 2Bionovo to Advance Menerba to Phase 3 Clinical Testing in Europe 3
(Date:9/29/2014)... 2014 NAPW honors ... Heaven Sent Consultation , as a 2014 Professional ... this prestigious distinction for leadership in marriage and family ... women in the country, spanning virtually every industry and ... powerfully vibrant networking community with over 600,000 members and ...
(Date:9/29/2014)... Top10BestSEOHosting.com is a website dedicated to providing up-to-date ... headed by a team of experts and professionals ... and factual studies about the newest hosting products, ... , Top10BestSEOHosting.com has recently compared many Linux hosting ... and Bluehost are the most recommended suppliers for ...
(Date:9/29/2014)... (PRWEB) September 30, 2014 According to ... dates back more than 5000 years, and was worn ... Europe, when women's fashions moved in the direction of ... moving in another direction. Today, Fecbek, a leading online ... of men’s handbags. The new items are fashionable. ...
(Date:9/29/2014)... New York, NY (PRWEB) September 29, 2014 ... parenthood. Some parents get lucky when there little one can ... peep and takes consistent naps each day. For many parents, ... to perform if you're exhausted and consumed with stress. ... just assumed that like other babies she would fall ...
(Date:9/29/2014)... TX (PRWEB) September 29, 2014 Dr. ... for over 25 years in his hometown, returns to ... general Neurosurgical and Spine Center. , Over the last ... Darnall Army Hospital at Fort Hood and Lubbock. He ... of Neurosurgical Excellence devoted to the goal of excellence ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Announces Carmel T. Ross, Marriage and Family Therapist at Heaven Sent Consultation, a 2014 Professional Woman of the Year 2Health News:Top10BestSEOHosting.com: New Reviews for Linux Web Hosting Suppliers Available Online 2Health News:Mommy Blogger Offers Advice on Getting Your Baby to Sleep 2Health News:Mommy Blogger Offers Advice on Getting Your Baby to Sleep 3Health News:Houston Neuro & Spine Surgery Plans to Develop Center of Neurosurgical Excellence 2
... study says, and that early exposure influences young people to ... Young people who start smoking may be influenced to do ... suggests. , What,s more, the study found that almost 80 ... through films rated "G," "PG" and "PG-13." , "Movies seen ...
... to Prevent Sudden Cardiac Arrest Through Public,Education and Advocacy, ... (SCAA) announced today that it has launched a South ... to help carry out its,mission of preventing sudden cardiac ... by Elliot Fisch of Boca Raton, Florida,who has long ...
... Will Work to Prevent Sudden Cardiac Arrest, Through ... The Sudden Cardiac Arrest,Association (SCAA) announced today that it ... network of local organizations to help carry out,its mission ... SCAA chapter is led by Connie Snell of Austin ...
... Life Coach Sherri Ziff Lester Says Small Steps Are Key to Gradual ... New Year,s Resolution Success, ... to lose weight, quit smoking or eat healthier for the,next 365 days. ... there seemed to be a shortage of fresh fruit and veggies at,grocery ...
... Older men with chronic anxiety are at substantially higher risk, ... men who suffer from chronic anxiety substantially increase their risk ... While stress has been linked to an increased risk of ... has been identified as a risk factor also. , "There ...
... 7, 2007 Scientists at Washington University School of ... better understand a collection of proteins associated with the ... movement. , The cell,s ability to move is important ... how immune system cells pursue disease-causing invaders and how ...
Cached Medicine News:Health News:Smoking in Movies Linked to Kids Lighting Up 2Health News:Smoking in Movies Linked to Kids Lighting Up 3Health News:Sudden Cardiac Arrest Association Launches South Florida Chapter 2Health News:Sudden Cardiac Arrest Association Launches South Florida Chapter 3Health News:Sudden Cardiac Arrest Association Launches Austin and Lubbock Chapters 2Health News:Sudden Cardiac Arrest Association Launches Austin and Lubbock Chapters 3Health News:Ring In 2008 With Simple New Year's Resolutions That Will Stick Year-Round 2Health News:Ring In 2008 With Simple New Year's Resolutions That Will Stick Year-Round 3Health News:Anxiety Raises Heart Attack Risk 2Health News:Anxiety Raises Heart Attack Risk 3Health News:Insights into cell movement likely to aid immune study, cancer research 2Health News:Insights into cell movement likely to aid immune study, cancer research 3
... System uses Cooled ThermoTherapy® (transurethral ... precisely targeted microwave energy deep ... coagulative necrosis for durable clinical ... continually monitors urethral and rectal ...
Fast, accurate SpO2 measurements always within reach....
Incontinence Pessaries...
Incontinence Dish - Stress Incontinence with mild prolapse. Incontinence Dish with support - Stress Incontinence with mild prolapse and mild cystocele...
Medicine Products: